Holen Sie sich die Stockscreener-App
16.62
2.58%
-0.44
Handel nachbörslich:
16.62
Schlusskurs vom Vortag:
$17.06
Offen:
$17
24-Stunden-Volumen:
1.48M
Relative Volume:
0.84
Marktkapitalisierung:
$3.98B
Einnahmen:
$401.20M
Nettoeinkommen (Verlust:
$-283.01M
KGV:
-11.96
EPS:
-1.39
Netto-Cashflow:
$121.56M
1W Leistung:
-10.16%
1M Leistung:
-10.74%
6M Leistung:
-17.48%
1J Leistung:
-10.31%
1-Tages-Spanne:
$16.60
$17.18
1-Wochen-Bereich:
$16.60
$18.63
52-Wochen-Spanne:
$13.10
$26.30
Cellebrite Di Ltd Stock (CLBT) Company Profile
Firmenname
Cellebrite Di Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
16.62 | 4.17B | 401.20M | -283.01M | 121.56M | -1.39 |
|
MSFT
Microsoft Corporation
|
517.03 | 3.85T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
257.85 | 748.65B | 59.02B | 12.63B | -5.88B | 4.3198 |
|
PLTR
Palantir Technologies Inc
|
207.18 | 475.58B | 3.44B | 772.57M | 1.71B | 0.3009 |
|
CRWD
Crowdstrike Holdings Inc
|
551.92 | 136.27B | 4.34B | -298.19M | 1.04B | -1.1966 |
|
SNPS
Synopsys Inc
|
445.72 | 84.30B | 6.43B | 1.15B | 1.30B | 12.77 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Bestätigt | Needham | Buy |
| 2024-03-13 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2021-12-02 | Eingeleitet | BofA Securities | Buy |
| 2021-10-21 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
Is Cellebrite DI Ltd. stock a defensive play in 2025Analyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Will Cellebrite DI Ltd. stock return to pre crisis levelsAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
How Cellebrite DI Ltd. stock performs in stagflationJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Cellebrite DI Ltd. stock outlook for YEARPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can Cellebrite DI Ltd. stock sustain institutional interest2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Detecting support and resistance levels for Cellebrite DI Ltd.July 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
Will Cellebrite DI Ltd. stock recover faster than peersQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Is Cellebrite DI Ltd. (9W9) stock safe for risk averse investorsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
Cellebrite Appoints Holly Windham As General Counsel - Security Informed
Cellebrite welcomes Holly Windham as General Counsel - SourceSecurity.com
Will Cellebrite DI Ltd. stock benefit from infrastructure spendingTrade Volume Report & Safe Entry Zone Identification - newser.com
Using Ichimoku Cloud for Cellebrite DI Ltd. technicals2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com
Cellebrite DI Ltd. $CLBT Stake Lessened by State of New Jersey Common Pension Fund D - MarketBeat
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
How to monitor Cellebrite DI Ltd. with trend dashboardsWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
Using Python tools to backtest Cellebrite DI Ltd. strategiesJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Identifying reversal signals in Cellebrite DI Ltd.Portfolio Value Summary & High Conviction Investment Ideas - newser.com
Is it time to cut losses on Cellebrite DI Ltd.2025 Volatility Report & Short-Term Trading Alerts - newser.com
Using Bollinger Bands to evaluate Cellebrite DI Ltd.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com
Will Cellebrite DI Ltd. (9W9) stock benefit from mergersWeekly Trading Summary & Fast Gaining Stock Reports - newser.com
Forecasting Cellebrite DI Ltd. price range with options dataPortfolio Risk Summary & Stock Market Timing Techniques - newser.com
Is Cellebrite DI Ltd. meeting your algorithmic filter criteriaJuly 2025 Pullbacks & Long-Term Growth Plans - newser.com
Israeli Forensics Co. Cellebrite Hires New GC - Law360
Will Cellebrite DI Ltd. (9W9) stock enhance shareholder valueBond Market & Real-Time Stock Price Movement Reports - newser.com
How to build a dashboard for Cellebrite DI Ltd. stockJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Measuring Cellebrite DI Ltd.’s beta against major indicesJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
Cellebrite appoints Holly Windham as general counsel and CCO - Investing.com
Cellebrite DI Ltd. (CLBT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Digital Forensics Firm Cellebrite Names Legal/Compliance Chief - Bloomberg Law News
Cellebrite appoints Holly Windham as general counsel and CCO By Investing.com - Investing.com Nigeria
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer - The Manila Times
Revenues Not Telling The Story For Cellebrite DI Ltd. (NASDAQ:CLBT) - 富途牛牛
Finanzdaten der Cellebrite Di Ltd-Aktie (CLBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.16%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):